- Udyam number
- UDYAM-DL-11-0018066

About Sidhaant Life Sciences Private Limited
Data last updated:
Sidhaant Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 October 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2004PTC129632. Its GSTIN is 07AAICS4211N1Z6 (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹76.5 Lakh. It is led by directors including Sudarshan Sabharwal and Jetender Sabharwal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 808 8th Floor Vishal Towerdistrict Centre Janakpuri, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2025, the company reported a revenue of ₹146.4 Cr, a growth of 71% compared to the previous year. For the same year it recorded a net profit of ₹5.36 Cr (net margin 3.7%) and EBITDA of ₹10.77 Cr (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 7% over five years.
The company has about 16 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sidhaant Life Sciences. As per MCA filings, the company has open charges of ₹24.64 Cr and satisfied charges of ₹11 Cr on record. Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it. The company has 7 deals on record (4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹65.9 Lakh; the latest was in December 2023. Its 7 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 4 smaller; the largest is Amvigor Organics Private Limited with revenue of ₹151.34 Cr.
Sidhaant Life Sciences Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-DL-11-0018066). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website smplgroup.org.
Company details
Recognitions & Rankings of Sidhaant Life Sciences
Contact details
Sidhaant Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its website is smplgroup.org. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address808 8th Floor Vishal Towerdistrict Centre Janakpuri, New Delhi, Delhi, India – 110058
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sidhaant Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Sidhaant Life Sciences operates one associated brand: Sidhaant Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of pharmaceutical products with a focus on export market | sidhaantlifesciences.com |
Business activity
The main business activity of Sidhaant Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sidhaant Life Sciences Private Limited, buy the company report.
Financials of Sidhaant Life Sciences Private Limited
FY 2024 filings availableSidhaant Life Sciences Private Limited reported revenue of ₹146.4 Cr (up 71% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 71% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.77 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.36 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.4% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sidhaant Life Sciences Private Limited, buy the company report.
Board of directors of Sidhaant Life Sciences Private Limited
Sidhaant Life Sciences has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudarshan Sabharwal | Director | 01 Oct 2004 | 22 Years 1 Months | Current |
| Jetender Sabharwal Also directs: Sabharwal Medicos LLP, Alma Mater Agencies Private Limited | Director | 01 Oct 2004 | 22 Years 1 Months | Current |
| Anu Nayyar | Director | 31 Mar 2017 | 9 Years 7 Months | Current |
| Sidhaant Sabharwal Also directs: Suave Med Sciences Private Limited | Additional Director | 31 May 2018 | 8 Years 5 Months | Current |
| Sulabh Nayyar | Director | 15 Jun 2009 | 17 Years 5 Months | Current |
Peer comparison
Sidhaant Life Sciences Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amvigor Organics Private Limited | ₹151.34 Cr (FY 2025) | 46.0% | Mumbai, Maharashtra, India | |||
| Kapbro Pharma Private Limited | ₹149.03 Cr (FY 2024) | 32.0% | New Delhi, Delhi, India | |||
| Caritas Healthcare Private Limited | ₹146.85 Cr (FY 2025) | 39.0% | Ahmedabad, Gujarat, India | |||
| Sidhaant Life Sciences Private Limitedthis company | ₹146.4 Cr (FY 2025) | ₹5.36 Cr | 3.7% | 71.0% | 16 | New Delhi, Delhi, India |
| N.R. Pharmaceuticals Private Limited | ₹144.8 Cr (FY 2024) | 13.0% | Kolkata, West Bengal, India | |||
| Sinkhai Healthcare Limited | ₹144.67 Cr (FY 2025) | 18.0% | Mumbai, Maharashtra, India | |||
| Doshi Medicare Private Limited | ₹143.56 Cr (FY 2024) | 6.0% | Mumbai, Maharashtra, India | |||
| Milton Medicare Private Limited | ₹143.31 Cr (FY 2025) | 11.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Sidhaant Life Sciences Private Limited, buy the company report.
Auditor
Sidhaant Life Sciences Private Limited is audited by J.S. SACHDEVA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J.S. SACHDEVA & CO. | FY 2023 | 017415N |
Shareholding
The shareholding of Sidhaant Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sidhaant Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Sep 2025 | 101177941 | Others | ₹60 Lakh | Open | |
| 28 Sep 2024 | 101014422 | Hdfc Bank Limited | ₹1.24 Cr | Open | |
| 25 May 2022 | 100597011 | Hdfc Bank Limited | ₹1.5 Cr | Open | |
| 02 Dec 2021 | 100531363 | Axis Bank Limited | ₹89.8 Lakh | Open | |
| 19 Mar 2021 | 100435021 | Others | ₹2.4 Cr | Open |
To see the full charge records of Sidhaant Life Sciences Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Sidhaant Life Sciences Private Limited has 7 deals on record (4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹65.9 Lakh; the latest was in December 2023.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 4 individuals |
| Mar 2017 | Funding round | ₹26.5 Lakh | Investors: 4 individuals |
| Mar 2015 | Funding round | ₹30 Lakh | Investors: 4 individuals |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
To see the full deal history of Sidhaant Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Sidhaant Life Sciences Private Limited has 5 court cases on record: 1 filed by Sidhaant Life Sciences, 4 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 0 |
| High courts | 1 | 0 | 0 |
Cases on record (3 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South West, Delhi | Civil suit | Filed against the company by State | Disposed |
| District court, South West, Delhi | Civil suit | Filed against the company by State | Disposed |
| High Court of Delhi | Writ petition | Filed by the company against an individual | Disposed |
To see the full case history of Sidhaant Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Sidhaant Life Sciences Private Limited was last rated by Crisil on 20 Aug 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 20 Aug 2020 |
To see the full credit ratings and regulatory alerts of Sidhaant Life Sciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sidhaant Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sidhaant Life Sciences Private Limited has a workforce of 16 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 16 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 |
To see the full employee and EPFO history of Sidhaant Life Sciences Private Limited, buy the company report.
GST
Sidhaant Life Sciences has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICS4211N1Z6 | Delhi | Active | 01 Jul 2017 |
| 06AAICS4211N1Z8 | Haryana | Active | 02 Jan 2020 |
To see the full GST registrations and return filing status of Sidhaant Life Sciences Private Limited, buy the company report.
Recent activity
Sidhaant Life Sciences Private Limited has 8 board changes on record since 2004: 5 appointments and 3 cessations. The latest: Sidhaant Sabharwal was appointed as Additional Director on 31 May 2018.
9 earlier events are in the company report.
Frequently asked questions
Sidhaant Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 October 2004 (22+ years old) and is registered under CIN U51397DL2004PTC129632.
Sidhaant Life Sciences has 5 current directors:
- Sudarshan Sabharwal - Director
- Jetender Sabharwal - Director
- Anu Nayyar - Director
- Sidhaant Sabharwal - Additional Director
- Sulabh Nayyar - Director
The latest financial statements of Sidhaant Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Sidhaant Life Sciences is 07AAICS4211N1Z6, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAICS4211N1Z8 (Haryana).
The CIN (Corporate Identification Number) of Sidhaant Life Sciences is U51397DL2004PTC129632. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sidhaant Life Sciences has 5 court cases on record: 1 filed by the company and 4 filed against it. Most are in the district courts.
Sidhaant Life Sciences was incorporated on 01 October 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
Sidhaant Life Sciences has 7 deals on record (4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹65.9 Lakh; the latest was in December 2023.
The peers of Sidhaant Life Sciences by revenue are Amvigor Organics Private Limited, Kapbro Pharma Private Limited, Caritas Healthcare Private Limited, N.R. Pharmaceuticals Private Limited, Sinkhai Healthcare Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Sidhaant Sabharwal was appointed as Additional Director on 31 May 2018. Anu Nayyar ceased to be Additional Director on 30 Sep 2017. Tanya Sethi ceased to be Additional Director on 30 Sep 2017. Sidhaant Life Sciences has 8 board changes on record in total.
Yes, Sidhaant Life Sciences is registered as an MSME under Udyam registration (number: UDYAM-DL-11-0018066).

